IBDEI038 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1145,1,4,0)
 ;;=4^447.6
 ;;^UTILITY(U,$J,358.3,1145,1,5,0)
 ;;=5^Arteritis
 ;;^UTILITY(U,$J,358.3,1145,2)
 ;;=^10396
 ;;^UTILITY(U,$J,358.3,1146,0)
 ;;=453.0^^13^114^55
 ;;^UTILITY(U,$J,358.3,1146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1146,1,4,0)
 ;;=4^453.0
 ;;^UTILITY(U,$J,358.3,1146,1,5,0)
 ;;=5^Thrombus Hepatic V
 ;;^UTILITY(U,$J,358.3,1146,2)
 ;;=^56228
 ;;^UTILITY(U,$J,358.3,1147,0)
 ;;=453.1^^13^114^54
 ;;^UTILITY(U,$J,358.3,1147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1147,1,4,0)
 ;;=4^453.1
 ;;^UTILITY(U,$J,358.3,1147,1,5,0)
 ;;=5^Thrombophlebitis Migra
 ;;^UTILITY(U,$J,358.3,1147,2)
 ;;=^265511
 ;;^UTILITY(U,$J,358.3,1148,0)
 ;;=453.2^^13^114^49
 ;;^UTILITY(U,$J,358.3,1148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1148,1,4,0)
 ;;=4^453.2
 ;;^UTILITY(U,$J,358.3,1148,1,5,0)
 ;;=5^Thombus Vena Cava
 ;;^UTILITY(U,$J,358.3,1148,2)
 ;;=^269817
 ;;^UTILITY(U,$J,358.3,1149,0)
 ;;=453.3^^13^114^60
 ;;^UTILITY(U,$J,358.3,1149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1149,1,4,0)
 ;;=4^453.3
 ;;^UTILITY(U,$J,358.3,1149,1,5,0)
 ;;=5^Thrombus Renal Vein
 ;;^UTILITY(U,$J,358.3,1149,2)
 ;;=^269818
 ;;^UTILITY(U,$J,358.3,1150,0)
 ;;=459.2^^13^114^47
 ;;^UTILITY(U,$J,358.3,1150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1150,1,4,0)
 ;;=4^459.2
 ;;^UTILITY(U,$J,358.3,1150,1,5,0)
 ;;=5^Stricture Vein
 ;;^UTILITY(U,$J,358.3,1150,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,1151,0)
 ;;=459.81^^13^114^38
 ;;^UTILITY(U,$J,358.3,1151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1151,1,4,0)
 ;;=4^459.81
 ;;^UTILITY(U,$J,358.3,1151,1,5,0)
 ;;=5^Chronic Venous Insuf
 ;;^UTILITY(U,$J,358.3,1151,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,1152,0)
 ;;=451.11^^13^114^42
 ;;^UTILITY(U,$J,358.3,1152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1152,1,4,0)
 ;;=4^451.11
 ;;^UTILITY(U,$J,358.3,1152,1,5,0)
 ;;=5^Phleb/Throm Fem V Deep
 ;;^UTILITY(U,$J,358.3,1152,2)
 ;;=^269811
 ;;^UTILITY(U,$J,358.3,1153,0)
 ;;=438.89^^13^114^37
 ;;^UTILITY(U,$J,358.3,1153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1153,1,4,0)
 ;;=4^438.89
 ;;^UTILITY(U,$J,358.3,1153,1,5,0)
 ;;=5^CVA, Late Effect
 ;;^UTILITY(U,$J,358.3,1153,2)
 ;;=^317924
 ;;^UTILITY(U,$J,358.3,1154,0)
 ;;=453.89^^13^114^59
 ;;^UTILITY(U,$J,358.3,1154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1154,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,1154,1,5,0)
 ;;=5^Thrombus Other Vein
 ;;^UTILITY(U,$J,358.3,1154,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,1155,0)
 ;;=444.01^^13^114^45
 ;;^UTILITY(U,$J,358.3,1155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1155,1,4,0)
 ;;=4^444.01
 ;;^UTILITY(U,$J,358.3,1155,1,5,0)
 ;;=5^Saddle Embolus-Abd Aorta
 ;;^UTILITY(U,$J,358.3,1155,2)
 ;;=^340522
 ;;^UTILITY(U,$J,358.3,1156,0)
 ;;=444.09^^13^114^40
 ;;^UTILITY(U,$J,358.3,1156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1156,1,4,0)
 ;;=4^444.09
 ;;^UTILITY(U,$J,358.3,1156,1,5,0)
 ;;=5^Oth Art Emb/Thrm Abd Aorta
 ;;^UTILITY(U,$J,358.3,1156,2)
 ;;=^340523
 ;;^UTILITY(U,$J,358.3,1157,0)
 ;;=078.5^^13^115^1
 ;;^UTILITY(U,$J,358.3,1157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1157,1,4,0)
 ;;=4^078.5
 ;;^UTILITY(U,$J,358.3,1157,1,5,0)
 ;;=5^CMV Infection
 ;;^UTILITY(U,$J,358.3,1157,2)
 ;;=^30676
 ;;^UTILITY(U,$J,358.3,1158,0)
 ;;=420.90^^13^115^13
 ;;^UTILITY(U,$J,358.3,1158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1158,1,4,0)
 ;;=4^420.90
 ;;^UTILITY(U,$J,358.3,1158,1,5,0)
 ;;=5^Pericarditis, Acute
 ;;^UTILITY(U,$J,358.3,1158,2)
 ;;=^269692
 ;;^UTILITY(U,$J,358.3,1159,0)
 ;;=420.91^^13^115^12
 ;;^UTILITY(U,$J,358.3,1159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1159,1,4,0)
 ;;=4^420.91
